Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Cornelia A. Verberkt, Marieke H. J. van den Beuken-van Everdingen, Carmen D. Dirksen, Jos M. G. A. Schols, Lowie E. G. W. Vanfleteren, Frits M. E. Franssen, Miriam T. J. Groenen, Emiel F. M. Wouters & Daisy J. A. Janssen. (2021) Healthcare and Societal Costs in Patients with COPD and Breathlessness after Completion of a Comprehensive Rehabilitation Program. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 170-180.
Read now
Read now
Ying-Huang Tsai, Tsung-Ming Yang, Chieh-Mo Lin, Shu-yi Huang & Yu-Wen Wen. (2017) Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2787-2793.
Read now
Read now
Maria Kamusheva, Maria Dimitrova, Job F. M. van Boven, Maarten J. Postma, Thys van der Molen, Janwillem W. H. Kocks, Konstantin Mitov, Miglena Doneva, Daniela Petrova, Ognyan Georgiev, Valentina Petkova & Guenka Petrova. (2017) Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria. Journal of Medical Economics 20:5, pages 503-509.
Read now
Read now
Miguel Román-Rodríguez, Job F. M. van Boven, Freya Vargas, Cecilia C. Contreras, Gema Lamelas, Salvador Gestoso, Miguel Góngora, Maite Corredor & Magdalena Esteva. (2016) Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain). European Journal of General Practice 22:4, pages 232-239.
Read now
Read now
Job FM van Boven, Janwillem WH Kocks & Maarten J Postma. (2016) Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2191-2201.
Read now
Read now
J.F.M. van Boven, A.G.G. Stuurman-Bieze, E.G. Hiddink & M.J. Postma. (2016) Effects of targeting disease and medication management interventions towards patients with COPD. Current Medical Research and Opinion 32:2, pages 229-239.
Read now
Read now
Sven-Arne Jansson, Helena Backman, Eva Rönmark, Bo Lundbäck & Anne Lindberg. (2015) Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD–A Report From the Population-Based OLIN COPD Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:4, pages 381-389.
Read now
Read now
Florian Kirsch. (2015) A systematic review of quality and cost–effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 301-316.
Read now
Read now
Articles from other publishers (29)
Uzochukwu Egere, Elizabeth H Shayo, Martha Chinouya, Miriam Taegtmeyer, Jane Ardrey, Stellah Mpagama, Nyanda Elias Ntinginya, Rana Ahmed, El Hafiz Hussein, Asma El Sony, Tom Wingfield, Angela Obasi, Rachel Tolhurst, Emmanuel Addo-Yobo, Brian Allwood, Hastings Banda, Imelda Bates, Amsalu Binegdie, Adegoke Falade, Jahangir Khan, Maia Lesosky, Bertrand Mbatchou, Hellen Meme, Kevin Mortimer, Beatrice Mutayoba, Louis Niessen, Jamie Rylance, William Worodria, Heather Zar, Eliya Zulu, Jeremiah Chakaya, Lindsay Zurba & S Bertel Squire. (2023) “Honestly, this problem has affected me a lot”: a qualitative exploration of the lived experiences of people with chronic respiratory disease in Sudan and Tanzania. BMC Public Health 23:1.
Crossref
Crossref
Subhasis Mukherjee, R. Chakraborti & D.K. Mukhopadhyay. (2022) Physical, Psycho-social and Economic Burden of Chronic Obstructive Pulmonary Disease: A Hospital-Based Study in Kolkata, West Bengal, India. The Indian Journal of Chest Diseases and Allied Sciences 63:2, pages 81-88.
Crossref
Crossref
Rezwanul Rana, Jeff Gow, Clint Moloney, Alex King, Gerben Keijzers, Gavin Beccaria & Amy Mullens. (2020) Estimating the frequency and cost of emergency department presentations and hospitalisation of chronic obstructive pulmonary disease patients: A retrospective analysis from regional Queensland. Emergency Medicine Australasia 33:3, pages 491-498.
Crossref
Crossref
Cornelia A. Verberkt, Marieke H.J. van den Beuken-van Everdingen, Carmen D. Dirksen, Jos M.G.A. Schols, Emiel F.M. Wouters & Daisy J.A. Janssen. (2021) Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial. Respiratory Medicine 179, pages 106330.
Crossref
Crossref
Boudewijn J. H. Dierick, Bertine M. J. Flokstra-de Blok, Thys van der Molen, Núria Toledo-Pons, Miguel Román-Rodríguez, Borja G. Cosío, Joan B. Soriano, Janwillem W. H. Kocks & Job F. M. van Boven. (2021) Work absence in patients with asthma and/or COPD: a population-based study. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Désirée Vandenberghe & Johan Albrecht. (2020) The financial burden of non-communicable diseases in the European Union: a systematic review. European Journal of Public Health 30:4, pages 833-839.
Crossref
Crossref
Evelyn A. Brakema, Aizhamal Tabyshova, Rianne M. J. J. van der Kleij, Talant Sooronbaev, Christos Lionis, Marilena Anastasaki, Pham Le An, Luan Than Nguyen, Bruce Kirenga, Simon Walusimbi, Maarten J. Postma, Niels H. Chavannes & Job F. M. van Boven. (2019) The socioeconomic burden of chronic lung disease in low-resource settings across the globe – an observational FRESH AIR study. Respiratory Research 20:1.
Crossref
Crossref
Florian Kirsch, Anja Schramm, Larissa Schwarzkopf, Johanna I. Lutter, Boglárka Szentes, Manuel Huber & Reiner Leidl. (2019) Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study. Respiratory Research 20:1.
Crossref
Crossref
Tanja Fens, Simon van der Pol, Janwillem W.H. Kocks, Maarten J. Postma & Job F.M. van Boven. (2019) Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice. Value in Health 22:10, pages 1092-1101.
Crossref
Crossref
Virginia Recchia, Antonio Dodaro, Rosita B. Maglie & Carlo G. Leo. 2018. Health Care Delivery and Clinical Science. Health Care Delivery and Clinical Science
154
181
.
Roberto W. Dal Negro & Claudio F. Donner. 2018. Textbook of Pulmonary Rehabilitation. Textbook of Pulmonary Rehabilitation
273
282
.
Job F.M. van Boven. (2017) Costly comorbidities of COPD: the ignored side of the coin?. European Respiratory Journal 50:1, pages 1700917.
Crossref
Crossref
Alex ExuzidesChris ColbyAndrew H. BriggsDavid A. LomasMaureen P. M. H. Rutten-van MölkenMaggie TabbererMike ChambersHana MuellerovaNicholas LocantoreNancy A. RisebroughAfisi S. IsmailaSebastian Gonzalez-McQuire. (2015) Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study. Medical Decision Making 37:4, pages 453-468.
Crossref
Crossref
Virginia Recchia, Antonio Dodaro, Rosita B. Maglie & Carlo G. Leo. 2017. Transformative Healthcare Practice through Patient Engagement. Transformative Healthcare Practice through Patient Engagement
29
65
.
Simon van der Schans, Lucas M. A. Goossens, Melinde R. S. Boland, Janwillem W. H. Kocks, Maarten J. Postma, Job F. M. van Boven & Maureen P. M. H. Rutten-van Mölken. (2016) Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. PharmacoEconomics 35:1, pages 43-63.
Crossref
Crossref
Jasvinder A. Singh & Shaohua Yu. (2016) Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respiratory Research 17:1.
Crossref
Crossref
Job F.M. van Boven, Dermot Ryan, Michelle N. Eakin, Giorgio W. Canonica, Aji Barot & Juliet M. Foster. (2016) Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations. The Journal of Allergy and Clinical Immunology: In Practice 4:5, pages 835-846.
Crossref
Crossref
Dionisios Spyratos, Diamantis Chloros, Dionisia Michalopoulou & Lazaros Sichletidis. (2016) Estimating the extent and economic impact of under and overdiagnosis of chronic obstructive pulmonary disease in primary care. Chronic Respiratory Disease 13:3, pages 240-246.
Crossref
Crossref
Miguel Román-Rodríguez, Marina Garcia Pardo, Lucia Gorreto López, Ana Uréndez Ruiz & Job FM van Boven. (2016) Enhancing the use of Asthma and COPD Assessment Tools in Balearic Primary Care (ACATIB): a region-wide cluster-controlled implementation trial. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Yi-Ting Chen, Yung-Hsiang Ying, Koyin Chang & Ya-Hui Hsieh. (2016) Study of Patients’ Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan. International Journal of Environmental Research and Public Health 13:3, pages 273.
Crossref
Crossref
Job F M van Boven, Miguel Román-Rodríguez, Janwillem W H Kocks, Joan B Soriano, Maarten J Postma & Thys van der Molen. (2015) Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol. npj Primary Care Respiratory Medicine 25:1.
Crossref
Crossref
David M. Mannino, Keiko Higuchi, Tzy-Chyi Yu, Huanxue Zhou, Yangyang Li, Haijun Tian & Kangho Suh. (2015) Economic Burden of COPD in the Presence of Comorbidities. Chest 148:1, pages 138-150.
Crossref
Crossref
Layal Chaker, Abby Falla, Sven J. van der Lee, Taulant Muka, David Imo, Loes Jaspers, Veronica Colpani, Shanthi Mendis, Rajiv Chowdhury, Wichor M. Bramer, Raha Pazoki & Oscar H. Franco. (2015) The global impact of non-communicable diseases on macro-economic productivity: a systematic review. European Journal of Epidemiology 30:5, pages 357-395.
Crossref
Crossref
Taulant Muka, David Imo, Loes Jaspers, Veronica Colpani, Layal Chaker, Sven J. van der Lee, Shanthi Mendis, Rajiv Chowdhury, Wichor M. Bramer, Abby Falla, Raha Pazoki & Oscar H. Franco. (2015) The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. European Journal of Epidemiology 30:4, pages 251-277.
Crossref
Crossref
Tzahit Simon-Tuval & Nimrod Maimon. (2015) Tiotropium as part of inhaled polytherapy: Adherence and associated health-care utilization. Respirology 20:2, pages 304-311.
Crossref
Crossref
Job FM van Boven, Joost J van Raaij, Ruben van der Galiën, Maarten J Postma, Thys van der Molen, PN Richard Dekhuijzen & Stefan Vegter. (2014) Impact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting β2-agonists: a dispensing database analysis. npj Primary Care Respiratory Medicine 24:1.
Crossref
Crossref
Job FM van Boven, Eline Tommelein, Koen Boussery, Els Mehuys, Stefan Vegter, Guy GO Brusselle, Maureen PMH Rutten-van Mölken & Maarten J Postma. (2014) Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis. Respiratory Research 15:1, pages 66.
Crossref
Crossref
Job F.M. van Boven, Niels H. Chavannes, Thys van der Molen, Maureen P.M.H. Rutten-van Mölken, Maarten J. Postma & Stefan Vegter. (2014) Clinical and economic impact of non-adherence in COPD: A systematic review. Respiratory Medicine 108:1, pages 103-113.
Crossref
Crossref
Yi-Ting Chen, Frank Ying, Koyin Chang & Ya-Hui Hsieh. (2016) Study of Patientss Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan. SSRN Electronic Journal.
Crossref
Crossref